Compare NUS & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUS | FOCL |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.9M | 193.0M |
| IPO Year | 1996 | 1998 |
| Metric | NUS | FOCL |
|---|---|---|
| Price | $4.65 | $4.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 429.5K | 71.5K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | ★ 207.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,176,718,000.00 | $70,527,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.14 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 48.98 | 1.63 |
| 52 Week Low | $4.49 | $4.00 |
| 52 Week High | $12.59 | $6.40 |
| Indicator | NUS | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | N/A |
| Support Level | $4.52 | N/A |
| Resistance Level | $4.96 | N/A |
| Average True Range (ATR) | 0.16 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 62.22 | 0.00 |
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.